Ultrasound in Medicine and Biology
Volume 33, Issue 2 , Pages 180-186 , February 2007

WFUMB safety symposium on ultrasound contrast agents: Clinical applications and safety concerns

  • Martin Blomley, MD

      Affiliations

    • Imaging Sciences Department, Imperial College, Hammersmith Hospital, London W12 0HS, UK
    • Martin Blomley passed away in 2006.
    • ,
  • Michel Claudon, MD

      Affiliations

    • Service de Radiologie, Rue du Morvan, 54511 Vandoeuvre Cedex, France
    • Corresponding Author InformationMichel Claudon, Service de Radiologie, Rue du Morvan, 54511 Vandoeuvre Cedex, France.
    • ,
  • David Cosgrove, MD

      Affiliations

    • Imaging Sciences Department, Imperial College, Hammersmith Hospital, London W12 0HS, UK
    • Corresponding Author InformationAddress correspondence to: David Cosgrove, Imaging Sciences Department, Imperial College, Hammersmith Hospital, London W12 0HS, UK.

References 

  1. Albrecht T, Urbank A, Mahler M, et al. Prolongation and optimization of Doppler enhancement with a microbubble US contrast agent by using continuous infusion: Preliminary experience. Radiology. 1998;207:339–347
  2. Albrecht T, Blomley MJ, Cosgrove DO, et al. Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent. Lancet. 1999;353(9164):1579–1583May 8
  3. Albrecht T, Barr R, Blomley M, et al. Seeking consensus: Contrast ultrasound in radiology. Invest Radiol. 2002;37:205–214
  4. Albrecht T, Blomley M, Bolondi L, et al. EFSUMB Study Group (Guidelines for the use of contrast agents in ultrasound. January 2004). Ultraschall Med. 2004;25(4):249–256
  5. Albrecht T, Blomley MJK, Burns PN, et al. Improved detection of hepatic metastases with pulse inversion ultrasonography during the liver-specific phase of SHU 508A (Levovist): A multicenter study. Radiology, in press.
  6. Ayida G, Harris P, Kennedy PS, Seif M, Barlow D, Chamberlain P. Hysterosalpingo-contrast sonography (HyCoSy) using Echovist-200 in the outpatient investigation of infertility patients. Br J Radiol. 1997;69:910–913
  7. Blomley MJK, Albrecht T, Cosgrove DO, et al. Liver vascular transit time analyzed with dynamic hepatic venography with bolus injections of an US contrast agent: Early experience in seven patients with metastases. Radiology. 1998;209:862–866
  8. Blomley MJK, Albrecht T, Cosgrove DO, Jayaram V, Butler-Barnes J. Stimulated acoustic emission in the liver parenchyma with the ultrasound contrast agent Levovist. Lancet. 1998;351:568
  9. Blomley MJK, Albrecht T, Cosgrove DO, et al. Improved imaging of liver metastases using stimulated acoustic emission in the late enhancement phase of the ultrasound contrast agent Levovist, early experience. Radiology. 1999;210(2):409–416
  10. Blomley MJK, Sidhu PS, Cosgrove DO, et al. Do different types of liver lesion differ in their uptake of the microbubble SHU508 in its late liver phase: Early experience. Radiology. 2001;220(3):661–667
  11. Blomley MJK, Sidhu PS, Cosgrove DO, et al. Do liver lesions differ in their uptake of a liver specific microbubble imaged using a new non-linear technique (ADI): Results of a multicenter trial. Radiology. 2001;221(P):268
  12. Blomley MJK, Cooke J, Unger EC, Monaghan M, Cosgrove DO. Microbubble contrast agents: A new era in ultrasound. BMJ. 2001;322(7296):1222–1225
  13. Blomley MJK, Lim AK, Harvey CJ, et al. Liver microbubble transit time compared with histology and Child-Pugh score in diffuse liver disease: a cross-sectional study. Gut. 2003;52:1188–1193
  14. Bryant TH, Blomley MJK, Albrecht T, et al. Improved characterization of liver lesions with liver-phase uptake of liver-specific microbubbles: prospective multi-center study. Radiology. 2004;232:799–809
  15. Burns PN, Becher H. Handbook of contrast echocardiography. Frankfurt: Springer Verlag; 2000;
  16. Cheng S-C, Dy TC, Feinstein SB. Contrast echocardiography: Review and future directions. Am J Cardiol. 1998;81(12A):41G–48G
  17. Claudon M, Plouin PF, Baxter GM, Rohban T, Devos DM. Renal arteries in patients at risk of renal arterial stenosis: multicenter evaluation of the echo-enhancer SH U 508A at color and spectral Doppler US. Levovist Renal Artery Stenosis Study Group. Radiology. 2000;214(3):739–746
  18. Cohen JL, Cheirif J, Segar DS, et al. Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent (Results of a phase III multicentre trial). J Am Coll Cardiol. 1998;32:746–752
  19. Cwajg J, Xie F, O’Leary E, Kricsfeld D, Dittrich H, Porter TR. Detection of angiographically significant coronary artery disease with accelerated intermittent imaging after intravenous administration of ultrasound contrast material. Am Heart J. 2000;139:675–683
  20. Czitrom D, Karila-Cohen D, Brochet E, et al. Acute assessment of microvascular perfusion patterns by myocardial contrast echocardiography during myocardial infarction: Relation to timing and extent of functional recovery. Heart. 1999;81:12–16
  21. Darge K, Troeger J, Duetting T, et al. Reflux in young patients: comparison of voiding US of the bladder and retrovesical space with echo enhancement versus voiding cystourethography for diagnosis. Radiology. 1999;210:201–207
  22. Eckersley RJ, Sedelaar JP, Blomley MJ, et al. Quantitative microbubble enhanced transrectal ultrasound as a tool for monitoring hormonal treatment of prostate carcinoma. Prostate. 2002;51(4):256–267
  23. EMEA/CPMP/212/04. Public statement on SonoVue. New contraindications in patients with heart disease. Restrictions of use to non-cardiac imaging. European Agency for the Evaluation of Medicinal Products. www.emea.eu.int
  24. EMEA/CPMP/213/04. Questions and answers on SonoVue. European Agency for the Evaluation of Medicinal Products. www.emea.eu.int
  25. Forsberg F, Shi WT. Physics of contrast microbubbles. In:  Goldberg BB,  Raichen JS,  Forsberg F editor. Ultrasound contrast agents. 2nd ed. London: Martin Dunitz; 2001;p. 15–24
  26. In:  Goldberg BB,  Raichlen JS,  Forsberg F editor. Ultrasound contrast agents. 2nd ed. London: Martin Dunitz; 2001;
  27. Gramiak R, Shah PM. Echocardiography of the aortic root. Invest Radiol. 1968;3(5):356–366
  28. Harvey CJ, Blomley MJK, Eckersley RJ, et al. Pulse inversion mode imaging of liver specific microbubbles: improved detection of subcentimetre metastases. Lancet. 2000;355(9206):807–808
  29. Harvey CJ, Blomley MJK, Lynch M, Eckersley RJ, Pilcher J, Cosgrove DO. Liver vascular transit time measured using the carotid delay time with bolus injections of the microbubble Levovist can predict the presence of occult metastases in colorectal cancer. Radiology. 2001;221(P):269
  30. Harvey CJ, Lynch M, Blomley MJK, et al. Quantitation of real-time perfusion with the microbubble Optison using power pulse inversion mode in renal transplants. Eur Radiol. 2001;11(Suppl. 1):103
  31. Harvey CJ, Pilcher JM, Eckersley RJ, Blomley MJ, Cosgrove DO. Advances in ultrasound. Clin Radiol. 2002;57(3):157–177
  32. de Jong N. Physics of microbubble scattering. In:  Nanda N,  Schlief R,  Goldberg BB editor. Advances in echo imaging using contrast enhancement. 2nd ed. Lancaster, England: Kluwer Academic; 1997;p. 39–64
  33. Katamaya H, Yamaguchi K, Takashima T, et al. Full scale investigation into adverse reaction in Japan: Risk factor analysis. Invest Radiol. 1991;26:S33–S36
  34. Kim TK, Choi BI, Han JK, Hong HS, Park SH, Moon SG. Hepatic tumors: Contrast agent-enhancement patterns with pulse-inversion harmonic US. Radiology. 2000;216(2):411–417
  35. Lim AKP, Patel N, Eckersley RJ, et al. Evidence for a spleen and liver specific uptake of the ultrasound contrast agent SonoVue. Radiology. 2004;
  36. Marshall MM, Beese RC, Muiesan P, Sarma DI, O’Grady J, Sidhu PS. Assessment of portal venous system patency in the liver transplant candidate: A prospective study comparing ultrasound, microbubble-enhanced colour Doppler ultrasound, with arteriography and surgery. Clin Radiol. 2002;57(5):377–383
  37. Mulvagh SL, DeMaria AN, Feinstein SB, et al. Contrast echocardiography: current and future applications. J Am Soc Echocardiogr. 2000;13:331–342
  38. Porter TR, Xie F, Kilzer K. Intravenous perfluoropropane-exposed sonicated dextrose albumin produces myocardial contrast which correlates with coronary blood flow. J Am Soc Echocardiogr. 1995;8:710–718
  39. Quaia E, Blomley MJ, Patel S, et al. Initial observations on the effect of irradiation on the liver-specific uptake of Levovist. Eur J Radiol. 2002;41(3):192–199
  40. Ries F, Honisch C, Lambertz M, Schlief R. A transpulmonary contrast medium enhances the transcranial Doppler signal in humans. Stroke. 1993;24(12):1903–1909
  41. Sidhu PS, Dawson P. Adverse reactions, cause, prophylaxis and management. In:  Dawson P,  Cosgrove DO,  Grainger RG editor. Textbook of contrast media (ISSI medical media). Oxford: ISIS Medical; 1999;p. 99–119
  42. Solbiati L, Tonolini M, Cova L, Goldberg SN. The role of contrast-enhanced ultrasound in the detection of focal liver lesions. Eur Radiol. 2001;11(Suppl 3):E15–E26
  43. Strandell A, Bourne T, Bergh C, Granberg S, Asztely M, Thorburn J. The assessment of endometrial pathology and tubal patency: a comparison between the use of ultrasonography and X-ray hysterosalpingography for the investigation of infertility patients. Ultrasound Obstet Gynecol. 1999;14(3):200–204
  44. Tiemann K, Becher H, Schlosser T, et al. Are microbubbles free flowing tracers through the myocardium? Comparison of indicator-dilution curves obtained from dye-dilution and echocontrast using harmonic power Doppler imaging. Echocardiography. 2000;17(1):17–27
  45. Wei K, Jayaweera AR, Firoozan S, et al. Quantification of myocardial blood flow with ultrasound induced destruction of microbubbles administered as a constant venous infusion. Circulation. 1998;97:473–483

PII: S0301-5629(06)01735-2

doi: 10.1016/j.ultrasmedbio.2006.07.007

Ultrasound in Medicine and Biology
Volume 33, Issue 2 , Pages 180-186 , February 2007

Article Tools